Puccetti, E., & Ruthardt, M. (2004). Acute promyelocytic leukemia: PML/RARα and the leukemic stem cell. Leukemia, 18, 1169–1175.
Article CAS PubMed Google Scholar
Wang, Z.-Y., & Chen, Z. (2008). Acute promyelocytic leukemia: from highly fatal to highly curable. Blood, 111, 2505–2515.
Article CAS PubMed Google Scholar
Tomita, A., Kiyoi, H., & Naoe, T. (2013). Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia. International Journal of Hematology, 97, 717–725.
Article CAS PubMed Google Scholar
Sanz, M. A., Martín, G., González, M., León, A., Rayón, C., Rivas, C., Colomer, D., Amutio, E., Capote, F. J., Milone, G. A., De La Serna, J., Román, J., Barragán, E., Bergua, J., Escoda, L., Parody, R., Negri, S., Calasanz, M. J., & Bolufer, P. (2004). Programa de Estudio y Traitmiento de las Hemopatías Malignas (2004) Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Blood, 103, 1237–1243.
Article CAS PubMed Google Scholar
Filipowicz, W., Bhattacharyya, S. N., & Sonenberg, N. (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews. Genetics., 9, 102–114.
Article CAS PubMed Google Scholar
Berindan-Neagoe, I., Monroig, P. D. C., Pasculli, B., & Calin, G. A. (2014). MicroRNAome genome: A treasure for cancer diagnosis and therapy: miRNA knowledge for clinicians. CA: A Cancer Journal for Clinicians, 64, 311–336.
Xing, Y., Ruan, G., Ni, H., Qin, H., Chen, S., Gu, X., Shang, J., Zhou, Y., Tao, X., & Zheng, L. (2021). Tumor immune microenvironment and its related miRNAs in tumor progression. Frontiers in Immunology, 12, 624725.
Article CAS PubMed PubMed Central Google Scholar
Zhang, Z., Huang, Q., Yu, L., Zhu, D., Li, Y., Xue, Z., Hua, Z., Luo, X., Song, Z., Lu, C., Zhao, T., & Liu, Y. (2021). The role of miRNA in tumor immune escape and miRNA-based therapeutic strategies. Frontiers in Immunology, 12, 807895.
Article CAS PubMed Google Scholar
Ferragut Cardoso, A. P., Banerjee, M., Nail, A. N., Lykoudi, A., & States, J. C. (2021). miRNA dysregulation is an emerging modulator of genomic instability. Seminars in Cancer Biology, 76, 120–131.
Article CAS PubMed PubMed Central Google Scholar
Torres-Bustamante, M. I., Vazquez-Urrutia, J. R., Solorzano-Ibarra, F., & Ortiz-Lazareno, P. C. (2024). The role of miRNAs to detect progression, stratify, and predict relevant clinical outcomes in bladder cancer. International Journal of Molecular Sciences, 25, 2178.
Article CAS PubMed PubMed Central Google Scholar
Shi, W., Wartmann, T., Accuffi, S., Al-Madhi, S., Perrakis, A., Kahlert, C., Link, A., Venerito, M., Keitel-Anselmino, V., Bruns, C., Croner, R. S., Zhao, Y., & Kahlert, U. D. (2024). Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer. British Journal of Cancer, 130, 125–134.
Article CAS PubMed Google Scholar
Crisafulli, L., & Ficara, F. (2022). Micro‐RNAs: A safety net to protect hematopoietic stem cell self‐renewal. Wiley Interdisciplinary Reviews. RNA, 13, e1693.
Article CAS PubMed Google Scholar
Kim, M., Civin, C. I., & Kingsbury, T. J. (2019). MicroRNAs as regulators and effectors of hematopoietic transcription factors. Wiley interdisciplinary reviews. RNA, 10, e1537.
Pelosi, A., Careccia, S., Lulli, V., Romania, P., Marziali, G., Testa, U., Lavorgna, S., Lo-Coco, F., Petti, M. C., Calabretta, B., Levrero, M., Piaggio, G., & Rizzo, M. G. (2013). miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. Oncogene, 32, 3648–3654.
Article CAS PubMed Google Scholar
Zeng, C.-W., Chen, Z.-H., Zhang, X.-J., Han, B.-W., Lin, K.-Y., Li, X.-J., Wei, P.-P., Zhang, H., Li, Y., & Chen, Y.-Q. (2014). MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia. Autophagy, 10, 1726–1737.
Article CAS PubMed PubMed Central Google Scholar
Zhao, Y., Ye, W., Wang, Y.-D., & Chen, W.-D. (2022). HGF/c-Met: A Key Promoter in Liver Regeneration. Frontiers in Pharmacology, 13, 808855.
Article CAS PubMed PubMed Central Google Scholar
van der Voort, R., Taher, T. E., Derksen, P. W., Spaargaren, M., van der Neut, R., & Pals, S. T. (2000). The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation. Advances in Cancer Research, 79, 39–90.
Raj, S., Kesari, K. K., Kumar, A., Rathi, B., Sharma, A., Gupta, P. K., Jha, S. K., Jha, N. K., Slama, P., Roychoudhury, S., & Kumar, D. (2022). Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. Molecular Cancer, 21, 31.
Article CAS PubMed PubMed Central Google Scholar
Qin, T., Xiao, Y., Qian, W., Wang, X., Gong, M., Wang, Q., An, R., Han, L., Duan, W., Ma, Q., & Wang, Z. (2022). HGF/c-Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR/NGF axis. Cell Death & Disease, 13, 387.
Boromand, N., Hasanzadeh, M., ShahidSales, S., Farazestanian, M., Gharib, M., Fiuji, H., Behboodi, N., Ghobadi, N., Hassanian, S. M., Ferns, G. A., & Avan, A. (2018). Clinical and prognostic value of the C‐Met/HGF signaling pathway in cervical cancer. Journal of Cellular Physiology, 233, 4490–4496.
Article CAS PubMed Google Scholar
Gwang Kim, J., Kyun Sohn, S., Hwan Kim, D., Ho Baek Ji, Young Lee, N., Soo Suh, J., Chae, S.-C., Soo Lee, K., & Bo Lee, K. (2005). Clinical implications of angiogenic factors in patients with acute or chronic leukemia: Hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. Leukemia & Lymphoma, 46, 885–891.
Gutiérrez, N. C., López-Pérez, R., Hernández, J. M., Isidro, I., González, B., Delgado, M., Fermiñán, E., García, J. L., Vázquez, L., González, M., & San Miguel, J. F. (2005). Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia. Leukemia, 19, 402–409.
Li, H., Bi, K., Feng, S., Yan Wang, Y., & Zhu, C. (2022). MIR-140 targets lncRNA DNAJC3-AS1 to suppress cell proliferation in acute myeloid leukemia: AML proliferation and MIR-140 lncRNA DNAJC3-AS1 target. Mediterranean Journal of Hematology and Infectious Diseases, 14, e2022005.
Article PubMed PubMed Central Google Scholar
Li, H., Hou, J., Fu, Y., Zhao, Y., Liu, J., Guo, D., Lei, R., Wu, Y., Tang, L., & Fan, S. (2023). miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia. Annals of Hematology, 102, 3357–3367.
Article CAS PubMed Google Scholar
Maragkakis, M., Vergoulis, T., Alexiou, P., Reczko, M., Plomaritou, K., Gousis, M., Kourtis, K., Koziris, N., Dalamagas, T., & Hatzigeorgiou, A. G. (2011). DIANA-microT Web server upgrade supports Fly and Worm miRNA target prediction and bibliographic miRNA to disease association. Nucleic Acids Research, 39, W145–W148.
Article CAS PubMed PubMed Central Google Scholar
Chen, Y., & Wang, X. (2020). miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Research, 48, D127–D131.
Article CAS PubMed Google Scholar
Kehl, T., Kern, F., Backes, C., Fehlmann, T., Stöckel, D., Meese, E., Lenhof, H.-P., & Keller, A. (2020). miRPathDB 2.0: a novel release of the miRNA Pathway Dictionary Database. Nucleic Acids Research, 48, D142–D147.
Article CAS PubMed Google Scholar
McGeary, S. E., Lin, K. S., Shi, C. Y., Pham, T. M., Bisaria, N., Kelley, G. M., & Bartel, D. P. (2019). The biochemical basis of microRNA targeting efficacy. Science, 366, eaav1741.
Article CAS PubMed PubMed Central Google Scholar
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., Cerami, E., Sander, C., & Schultz, N. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6, pl1.
Comments (0)